Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
50,640,999
-
Share change
-
-247,326
-
Total reported value
-
$5,643,804,733
-
Put/Call ratio
-
80%
-
Price per share
-
$111.43
-
Number of holders
-
390
-
Value change
-
-$78,575,975
-
Number of buys
-
229
-
Number of sells
-
155
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2016
As of 31 Mar 2016,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
390 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,640,999 shares.
The largest 10 holders included
FMR LLC, SCOPIA CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, BlackRock Fund Advisors, AJO, LP, STATE STREET CORP, DEUTSCHE BANK AG\, BlackRock Institutional Trust Company, N.A., Palo Alto Investors, LLC, and AQR CAPITAL MANAGEMENT LLC.
This page lists
390
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.